Area of research
Pulmonary and Respiratory Medicine · Gastroenterology
Research interest
Research interests include Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment, Cancer-related molecular mechanisms research, and RNA modifications and cancer.
SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer
SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer.
Clinical characteristics of gastrointestinal stromal tumors with lymph node metastasis: a retrospective single-center study
Chinese expert consensus on diagnosis and treatment of small gastrointestinal stromal tumors (2025 edition)
The management of imatinib-associated severe skin rash in gastrointestinal stromal tumor: desensitization therapy and pharmacogenetic investigation.
PARP1-mediated PARylation of TEAD4 stabilizes the YAP1-TEAD4 complex and promotes growth and immune evasion in breast cancer cells.
NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance
NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance.
Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression
OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway
DDR1 Drives Malignant Progression of Gastric Cancer by Suppressing HIF‐1α Ubiquitination and Degradation
Gastric Cancer Actively Remodels Mechanical Microenvironment to Promote Chemotherapy Resistance via MSCs‐Mediated Mitochondrial Transfer
DDR1 Drives Malignant Progression of Gastric Cancer by Suppressing HIF-1α Ubiquitination and Degradation.
The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention.
Gastric Cancer Actively Remodels Mechanical Microenvironment to Promote Chemotherapy Resistance via MSCs-Mediated Mitochondrial Transfer.
Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis
The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer
Gastric residual volume, safety, and effectiveness of drinking 250 mL of glucose solution 2-3 hours before surgery in gastric cancer patients: a multicenter, single-blind, randomized-controlled trial.
RNA methylation-related genes INHBB and SOWAHA are associated with MSI status in colorectal cancer patients and may serve as prognostic markers for predicting immunotherapy efficacy.
Construction and Preclinical evaluation of BCL3-Degrading PROTACs for Enhanced Colorectal Cancer Therapy
Gastrointestinal organs and organoids-on-a-chip: advances and translation into the clinics
Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers
Triple Tumor Microenvironment‐Responsive Ferroptosis Pathways Induced by Manganese‐Based Imageable Nanoenzymes for Enhanced Breast Cancer Theranostics
Metal-enriched HSP90 nanoinhibitor overcomes heat resistance in hyperthermic intraperitoneal chemotherapy used for peritoneal metastases
Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer
Lactate-Induced CCL8 in Tumor-Associated Macrophages Accelerates the Progression of Colorectal Cancer through the CCL8/CCR5/mTORC1 Axis
Construction of a hypoxia-immune-related prognostic panel based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer
PUM1 Promotes Tumor Progression by Activating DEPTOR‐Meditated Glycolysis in Gastric Cancer
The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention
Pumilio1 regulates NPM3/NPM1 axis to promote PD-L1-mediated immune escape in gastric cancer